Adverse cutaneous drug reaction
S Nayak, B Acharjya - Indian Journal of dermatology, 2008 - journals.lww.com
In everyday clinical practice, almost all physicians come across many instances of
suspected adverse cutaneous drug reactions (ACDR) in different forms. Although such …
suspected adverse cutaneous drug reactions (ACDR) in different forms. Although such …
Cutaneous adverse drug reactions in Indian population: A systematic review
TK Patel, SH Thakkar, DC Sharma - Indian dermatology online …, 2014 - journals.lww.com
Background: Epidemiological data is limited for cutaneous adverse drug reactions (CADRs)
in India. Most of the Indian studies have small sample size and are of limited duration. Aims …
in India. Most of the Indian studies have small sample size and are of limited duration. Aims …
Adverse cutaneous drug reactions: A one year survey at a dermatology outpatient clinic of a tertiary care hospital
S Chatterjee, AP Ghosh, J Barbhuiya… - Indian Journal of …, 2006 - journals.lww.com
South India had revealed that the mean age of ACDR was 37.06 year and the female-male
ratio being 0.87: 1. The common offending drug groups as depicted in Table 1 were …
ratio being 0.87: 1. The common offending drug groups as depicted in Table 1 were …
Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India
A Saha, NK Das, A Hazra, RC Gharami… - Indian journal of …, 2012 - journals.lww.com
Background: Cutaneous adverse drug reactions (CADR) are the most frequent of all
manifestations of drug sensitivity and manifest with varied and diverse morphology. Aims: To …
manifestations of drug sensitivity and manifest with varied and diverse morphology. Aims: To …
Clinical study of cutaneous drug eruptions in 200 patients
RM Patel, YS Marfatia - Indian journal of dermatology, venereology and …, 2008 - ijdvl.com
Background: Cutaneous drug reactions are the most common adverse reactions attributed to
drugs. Any skin disorder can be imitated, induced or aggravated by drugs. Aims: The present …
drugs. Any skin disorder can be imitated, induced or aggravated by drugs. Aims: The present …
[HTML][HTML] An appraisal of allergic disorders in India and an urgent call for action
India is the second most populous country in the world with a population of nearly 1.3 billion,
comprising 20% of the global population. There are an estimated 37.5 million cases of …
comprising 20% of the global population. There are an estimated 37.5 million cases of …
Clinical study of cutaneous drug eruptions in 200 patients
MP Raksha, YS Marfatia - Indian journal of dermatology, venereology and …, 2008 - ijdvl.com
Two hundred patients (112 males and 88 females) with cutaneous drug eruption were
studied. The aim was to recognize the offending drug, to evaluate mortality and morbidity …
studied. The aim was to recognize the offending drug, to evaluate mortality and morbidity …
Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective
R Nandha, A Gupta, A Hashmi - International journal of Applied …, 2011 - journals.lww.com
Background: Cutaneous manifestations of adverse drug reactions are a common occurrence
and need to be differentiated from other causes of similar manifestations. Active search is …
and need to be differentiated from other causes of similar manifestations. Active search is …
A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India
R Sharma, D Dogra, N Dogra - Indian dermatology online journal, 2015 - journals.lww.com
Aim: The aim was to study various morphological patterns of cutaneous adverse drug
reactions (CADRs) and identify the culprit drug or drugs by establishing a causal link using …
reactions (CADRs) and identify the culprit drug or drugs by establishing a causal link using …
[HTML][HTML] Causality, severity and preventability assessment of adverse cutaneous drug reaction: a prospective observational study in a tertiary care hospital
S Padmavathi, K Manimekalai… - Journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Introduction: The number of subjects involved in a clinical trial are limited, whose findings
cannot be extrapolated to the entire population. Due to the emergence of newer molecules …
cannot be extrapolated to the entire population. Due to the emergence of newer molecules …